57
CNS infections Ahmad Rizal Bagian Saraf FKUP / RSHS Bandung

INFEKSI CNS

  • Upload
    mylogyi

  • View
    130

  • Download
    6

Embed Size (px)

DESCRIPTION

INFEKSI CNS

Citation preview

Page 1: INFEKSI CNS

CNS infections

Ahmad RizalBagian Saraf FKUP / RSHS

Bandung

Page 2: INFEKSI CNS

Terminology

• Primarily affects its coverings meningitis• Affects the brain parenchyma encephalitis• Affects the spinal cord myelitis• A patient may have more than one affected

area, and if all are affected, the patient has "meningoencephalomyelitis“

• Localized pockets of infection:– Within the brain or spinal cord abscess– Outside them there epidural abscess or subdural

empyema

Page 3: INFEKSI CNS

Clinical syndromes

• Acute presentations: <2 days duration – bacterial process (pyogenic)– aggressive viral encephalitis

• Subacute presentations : broader spectrum of diagnostic possibilities– Tuberculous– Fungal– Parasitic– Viral– Non infectious: encephalopathy, ADEM, other

Page 4: INFEKSI CNS

Change in scenario

• Increase in immuno-compromised patients– AIDS– prolonged survival of cancer patients– organ transplantation

• Increase in international travel– rapid transmission to susceptible populations– new diseases

• Widespread antibiotic use– resistant organisms

Page 5: INFEKSI CNS

Signs and symptoms

• Headache

• Fever

• Neck stiffness (and other meningeal signs)

• Obtundation

Page 6: INFEKSI CNS

Diagnosis

• Suspicious clinical symptoms and signs

• CT of head to rule out abscess or other space-occupying lesion, if it can be done quickly

• Lumbar puncture

• Blood cultures

Page 7: INFEKSI CNS

Acute bacterial meningitis

• The big three: N.meningitides, S.pneumoniae, H.influenzae– Other: Listeria, pseudomonas, E.coli….

• Headache, fever, neck stiffness, obtundation• focal signs, seizures, rash, shock..• often fulminant

• CSF: high wbc (500- 20000 polymorphs), high protein, low glucose– But: partial treatment

• CT/MRI: may be normal

Page 8: INFEKSI CNS

Meningococcal septicaemia

Page 9: INFEKSI CNS

Meningococcal septicaemia Picture: With the friendly permission of  Dr. Noack (photographer) and Prof.Dittman, in whose book the picture appears (German title:"Meningokokkenerkrankungen”)

Meningococcaemia

Page 10: INFEKSI CNS

Bacterial meningitis: diagnosis

High index of suspicion

Prompt CSF examination

urgent smear for Gram stain

urgent latex agglutination testing for bacterial antigens (meningococcus, pneumococcus, H.infl) not a routine procedure in Bandung

Repeat CSF examination after 24 – 48 h

Page 11: INFEKSI CNS

Bacterial meningitis: antibiotics

• Ceftriaxone iv 4g; then 2g daily– cefotaxime– benzylpenecillin– chloramphenicol

• Resistant pneumococcus– add vancomycin 2g bd iv +/- rifampicin

• Listeria– ampicillin

• Pseudomonas– gentamicin

Page 12: INFEKSI CNS

Bacterial meningitis: steroids

– Significantly reduce mortality and neurological sequelae in adults with bacterial meningitis

– Should be used ROUTINELY in adults with suspected bacterial meningitis

– Best effect to pneumococcal infection– Give with/before 1st dose of antibiotics– 10mg dexa 6 hourly for 4 days– NOT in patients already started on antibiotics

(de Gaans, NEJM 2002; 347: 1549 – 56)– Caution: may reduce penetration through BBB

• especially vancomycin

Page 13: INFEKSI CNS

• Don’t give in– Late stage disease – may be harmful– septic shock– post neurosurgical meningitis– immunosuppressed/i.compromised patients

• Stop if– No pathogen identified on CSF smear and suspect

fungal/other infection– No bacterial growth/other organism after 24- 48 hours

Bacterial meningitis: steroids

Page 14: INFEKSI CNS

• Other anti-inflammatory drugs?– against CSF cytokines– matrix metalloproteases– reactive oxygen species

Bacterial meningitis: treatment

Page 15: INFEKSI CNS

Bacterial meningitis

Delay initiating treatmentDelay recognising complications

high mortalitymore complication

Page 16: INFEKSI CNS

Late deterioration

• Subdural effusion

• Empyema

• Hydrocephalus

• Vasculitis: – stroke– diffuse brain injury– oedema

• systemic

Page 17: INFEKSI CNS

Cerebral infarction

T2 DWI

Page 18: INFEKSI CNS

Subdural empyema

Page 19: INFEKSI CNS

Vasculitis and stroke

Page 20: INFEKSI CNS

Vasculitis, stroke, hydrocephalus

Page 21: INFEKSI CNS

Acute or subacute onset global cerebral dysfunction

• Three diagnostic categories

– Infective encephalitis (typically viral)

– Encephalopathy (typically metabolic or toxic)

– ADEM

Page 22: INFEKSI CNS

• Encephalopathy

– Mental status –steady decline

– Seizures –generalised

– Blood - wbc N– CSF – wbc N– EEG – diffuse slowing– MRI – often normal

• Encephalitis– Fever and headache

common– Mental status –often

fluctuates– Seizures – focal and

generalised– Focal signs common

– Blood – wbc – CSF- wbc – EEG – slow plus focal– MRI –often abnormal

Page 23: INFEKSI CNS

Encephalitis?

• The physician addresses three important questions:

– How likely is the diagnosis of encephalitis?

– What could be the cause of encephalitis?

– Which is the best treatment plan for the patient with encephalitis?

Page 24: INFEKSI CNS

Causes of viral encephalitis• Herpes simplex virus (HSV-1, HSV-2)

- treatable

• Other herpes viruses: VZV, CMV,EBV, human herpes virus 6 (HHV6)

• Adenoviruses

• Influenza A

• Enteroviruses, poliovirus

• Measles, mumps and rubella viruses

• Rabies

• Arboviruses— Japanese B encephalitis, West Nile encephalitis virus

• Bunyaviruses—La Crosse strain of California virus

• Reoviruses— Colorado tick fever virus

• Arenaviruses— lymphocytic choriomeningitis virus

Page 25: INFEKSI CNS

HSE

• Most commonly identified cause of viral encephalitis in the US (10-20% of cases)

• Estimated annual incidence: 1 in 250,000 to 500,000 persons

• Cases distributed throughout the year• Biphasic age distribution, with peaks at 5-

30 and >50 years of age• HSV-1 virus causes more than 95% of

cases

Page 26: INFEKSI CNS

HSE

• Without treatment, mortality >70%

• Major morbidity in survivors

• Milder forms of the illness exist but are rarely correctly identified

Page 27: INFEKSI CNS

HSE

• Clinical hallmark of HSV encephalitis: acute onset of fever and focal neurological symptoms

• Differentiation of HSV encephalitis from other processes is difficult.

• CSF , CT, MRI, PCR

• High index of suspicion– Even if CSF/imaging normal

Page 28: INFEKSI CNS

• Most common presentations include:– fever in up to 90%– severe headache– focal or generalized convulsions– alterations in behavior and consciousness– disorientation, dysphasia, and hemiparesis

more rare– motor paralysis present in < 50%

HSE

Page 29: INFEKSI CNS

HSV treatment

• Vidarabine: 1st effective antiviral therapy

• Acyclovir: proved more potent – reduced mortality to 19-28%, compared with

50-54% with vidarabine (Whitley et al, NEJM 1992)

– dosed 10 mg/kg given 8h for 10-14 days– toxicity rare: phlebitis, rash, ↑ transaminases,

GI disturbance, neurotoxicity

Page 30: INFEKSI CNS

Chronic meningitis

Signs and symptoms• Headache • Fever • Meningismus • Confusion • Hydrocephalus

In general, symptoms develop slowlyMeningismus may be mildThere may be subtle mental status changes

Page 31: INFEKSI CNS

Diagnosis

• Difficult diagnosis because signs and symptoms are often non-specific. It can be suspected in any patient with a chronic encephalopathy, or a patient with new onset of hydrocephalus

• MRI or CT of head may show hydrocephalus or contrast enhancement of the basal meninges

• Lumbar puncture

Page 32: INFEKSI CNS

Causes

• Infectious: – Bacterial– Fungal– Parasitic

• Non-infectious

Page 33: INFEKSI CNS

Infectious: • M. tuberculosis • Cryptococcus neoformans • HIV • Treponema pallidum • Nocardia sp. • Aspergillus sp. • Taenia solium (cysticercosis) • Toxoplasma gondii

Non-infectious: • Neoplasm (esp. breast, lung) • Neurosarcoidosis • Behcet's disease • CNS vasculitis • Mollaret's meningitis

Causes

Page 34: INFEKSI CNS

TBM

Page 35: INFEKSI CNS

TBM

• High mortality– mainly due to complications

• hydrocephalus• infarction• ventriculitis

• Rapid diagnosis difficult• High index of clinical suspicion

– Chronicity– Basal meningitis– Systemic illness– High risk groups

Page 36: INFEKSI CNS

Clinical features

• Fever, headache, meningismus and mental status changes

• Vomiting and other signs of increased intracranial pressure may occur

• Cranial nerve palsies occurs in approximately 25% of cases

• HIV infection is a risk factor for tuberculous meningitis• Other mycobacteria (M. avium, M. africanus) can

produce human disease, and M. avium is an opportunistic pathogen in AIDS patients

• Other involvement: – Spinal cord usually in the thoracic cord region– Tuberculous spondylitis psoas abscess, epidural abscess

Page 37: INFEKSI CNS

Cerebrospinal fluid

• lymphocytic pleocytosis• elevated protein• reduced glucose• Staining: positive in 5 to 25%• Culture: positive in approximately 60% of cases• CSF PCR may be useful

• With treatment, the CSF returns to normal slowly.  Glucose is the first to normalize, but it takes at least three weeks, and usually more

Page 38: INFEKSI CNS

Imaging

• Contrast-enhanced CT or MRI scans show a basilar meningitis, with contrast enhancement of the meninges in the suprasellar area, prepontine cistern, or interpeduncular fossa

• Obstructive or communicating hydrocephalus may occur

Page 39: INFEKSI CNS

TBM

Page 42: INFEKSI CNS

stroke

Page 43: INFEKSI CNS

tuberculous abcess

Page 44: INFEKSI CNS

TBM - diagnosis

Gold standard is microscopy: ZN staining

Page 45: INFEKSI CNS

TB culture

Page 46: INFEKSI CNS

TBM diagnosis: other

• CSF adenosine deaminase – unreliable: false positives– undefined in HIV

• PCR– good after treatment has begun

Page 47: INFEKSI CNS

TB

Page 48: INFEKSI CNS

TBM: treatment

• Quadruple therapy initially– Isoniazid– Rifampicin– Pyrazinamide– Ethambutol/streptomycin

• Steroids:– Coma– Dexamethasone 16mg/day 2-4 weeks

Page 49: INFEKSI CNS

Immunocompromised patients

• Multiple organisms in single or multiple organs

• Unusual organisms

• Decreased sensitivity diagnostic tests

• Atypical presentations – no fever in meningitis

• Clinical picture complicated– multi-organ failure

Page 50: INFEKSI CNS

AIDS/HIV

• Meningitis– Cryptococcus neoformans

• Encephalitis– CMV

• Brain abcess– Toxoplasma

Page 51: INFEKSI CNS

Aspergillus

Page 52: INFEKSI CNS

Nocardia

Page 53: INFEKSI CNS

Lumbar Puncture

Basically, LP should be undertaken on all patients with suspected CNS infection

Contraindications:

• signs of raised intracranial pressure—– altered pupillary responses, – Absent Doll’s eye reflex– decerebrate or decorticate posturing– abnormal respiratory pattern– Papilloedema– hypertension– bradycardia

Page 54: INFEKSI CNS

Contraindications (cont.):

• recent (within 30 minutes) or prolonged (over 30 minutes) convulsive seizures

• focal or tonic seizures• other focal neurological signs

– hemi/monoparesis– extensor plantar responses– ocular palsies

Lumbar Puncture

Page 55: INFEKSI CNS

Contraindications (cont.):

• Glasgow Coma Score < 13 or deteriorating level of consciousness

• Strong suspicion of meningococcal infection (typical purpuric rash in an ill child)

• State of shock• Local superficial infection• Coagulation disorder

Lumbar Puncture

Page 56: INFEKSI CNS

Typical CSF formulas

Bacterial Viral Fungal Tuberculous

opening pressure

normal or high normal normal or high usually high

WBC count (cells/mm3)

1,000-10,000 < 300 20-500 50-500

PMN (%) >80 <20 <50 ~20

RBC count (cells/mm3)

slight increase normal normal normal

protein (mg/dl)

very high (100-500)

normal high high

Glucose < 40 normal usually < 40 < 40

Gram stain  60-90 % positive

negative negativeAFB stain + in 40-80%

culture (% positive)

70-85 25 25-50 50-80

Page 57: INFEKSI CNS